Literature DB >> 8318503

Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated.

A Mennander1, T Paavonen, P Häyry.   

Abstract

Rat aortic allografts from the DA (RT1a) to the WF (RT1v) strain but not syngeneic DA-to-DA control grafts develop arteriosclerotic changes in the vascular wall that are virtually identical to human allografts during chronic rejection. A more prominent medial cell destruction in the rat aorta, leading ultimately to complete medial necrosis, is the major difference between rat and human allografts. If the adventitia of syngeneic grafts is exposed to starch before transplantation, these grafts also develop an inflammatory reaction in the adventitia and an extensive intimal thickening at the site of the granulomas, but the medial smooth muscle cells are preserved. In both types of transplants with an intact endothelium as determined by light microscopy, adventitial inflammatory cell proliferation was accompanied by smooth muscle cell replication in the media and thickening of the intima. We therefore propose that an adventitial proliferative response is a prerequisite for intimal thickening to occur. In the allograft but not in starch-exposed syngeneic grafts there was also a notable lymphoid activation in the adventitia, which was accompanied by medial necrosis. We suggest that the medial necrosis in the allograft is linked to a toxic effect of activated lymphoid cells on medial myocytes and is not a prerequisite for intimal proliferation. Instead, intimal proliferation and medial necrosis in the allograft seem to be independently regulated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318503     DOI: 10.1161/01.atv.13.7.1019

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  9 in total

1.  CD8+ T lymphocytes mediate destruction of the vascular media in a model of chronic rejection.

Authors:  J F Légaré; T Issekutz; T D Lee; G Hirsch
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance.

Authors:  V Subbotin; H Sun; A Aitouche; L A Valdivia; J J Fung; T E Starzl; A S Rao
Journal:  Transplantation       Date:  1997-09-15       Impact factor: 4.939

Review 3.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

4.  Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention.

Authors:  A J Demetris; N Murase; T E Starzl; J J Fung
Journal:  Graft (Georget Tex)       Date:  1998-05

Review 5.  Hyperfiltration nephropathy as a cause of late graft loss in renal transplantation.

Authors:  C Modlin; D Goldfarb; A C Novick
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

6.  Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection.

Authors:  Kevin Rey; Sukhbir Manku; Winnie Enns; Thea Van Rossum; Kevin Bushell; Ryan D Morin; Fiona S L Brinkman; Jonathan C Choy
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

7.  Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts.

Authors:  L M Akyürek; B C Fellström; Z Q Yan; G K Hansson; K Funa; E Larsson
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

Review 8.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.

Authors:  Wendy Anne Boivin; Dawn Michelle Cooper; Paul Ryan Hiebert; David James Granville
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.502

9.  Effects of angiopeptin on transplant arteriosclerosis in the rat.

Authors:  M L Akyürek; A Wanders; M Aurivillius; E Larsson; K Funa; B C Fellström
Journal:  Transpl Int       Date:  1995       Impact factor: 3.782

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.